Your browser doesn't support javascript.
loading
Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment.
De La Cruz, Elisa; Esselin, Florence; Polge, Anne; Mouzat, Kévin; Guissart, Claire.
Affiliation
  • De La Cruz E; University Hospital Centre of Montpellier, Montpellier, France e-delacruz@chu-montpellier.fr.
  • Esselin F; Institute for Neurosciences of Montpellier, Montpellier, France.
  • Polge A; University Hospital Centre of Montpellier, Montpellier, France.
  • Mouzat K; Institute for Neurosciences of Montpellier, Montpellier, France.
  • Guissart C; Laboratoire de Biochimie et Biologie Moléculaire, CHU Nimes, Nimes, France.
Article in En | MEDLINE | ID: mdl-38925911

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2024 Document type: Article Affiliation country: France Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2024 Document type: Article Affiliation country: France Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM